CVE-2012-0829

Public Exploit

Description

Multiple cross-site request forgery (CSRF) vulnerabilities in Mibew Messenger 1.6.4 and earlier allow remote attackers to hijack the authentication of operators for requests that insert cross-site scripting (XSS) sequences via the (1) address or (2) threadid parameters to operator/ban.php; or (3) geolinkparams, (4) title, or (5) chattitle parameters to operator/settings.php.

Category

6.0
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.22%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/72822 vdb entry
http://secunia.com/advisories/47787 third party advisory vendor advisory
http://www.securityfocus.com/bid/51723 vdb entry
http://archives.neohapsis.com/archives/bugtraq/2012-01/0178.html mailing list exploit
http://www.openwall.com/lists/oss-security/2012/02/02/10 mailing list
http://www.codseq.it/advisories/mibew_messenger_multiple_xss exploit

Frequently Asked Questions

What is the severity of CVE-2012-0829?
CVE-2012-0829 has been scored as a medium severity vulnerability.
How to fix CVE-2012-0829?
To fix CVE-2012-0829, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-0829 being actively exploited in the wild?
It is possible that CVE-2012-0829 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.